ClinicalTrials.gg
CompletedNCT03732053GPRUpdated Nov 19, 2019

The Effectiveness of Global Postural Reeducation on Alzheimer Disease Patients

An interventional study of GPR Intervention Research group in Alzheimer's Type Dementia, Cognitive Decline and Postural; Strain, sponsored by Universidad Católica San Antonio de Murcia. Completed. Open to participants aged 40 Years to 95 Years. Per ClinicalTrials.gov, last updated 2019-11-19.

Sponsored by Universidad Católica San Antonio de Murcia · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Dec 2016, registered Apr 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
135
Allocation
Randomized
Ages
40 Years to 95 Years
Sex
All
01

Study summary

This research study is developed on an experimental design with randomized controlled intervention were participated 135 subjects with AD including 45 of the control group. It lasted 6 months with pre-post tests (T0-T1) executed before and after six months of treatment. By having in focus the evaluation of GPR therapy effects on cognitive, proprioceptive, depressive, autonomy, gait and life quality of the above mentioned subjects.

Read the detailed description

In order to assess the cognitive abilities of the patients a cognitive test was administered which acts through a scale concerning depression and mood evaluation as well as a questionnaire was developed aiming to evaluate the examined subjects' functional abilities: Mini Mental State Examination (MMSE), Quality of Life in Alzheimer Disease (QoL-AD), geriatric Depression Scale (GDS), Barthel Index (BI), Neuropsychiatric Inventory (NPI), Tinetti Scale (TS).

02

Conditions studied

  • Alzheimer's Type Dementia
  • Cognitive Decline
  • Postural; Strain
03

In context

Cognitive Dysfunction

3,930 studies on the registry are indexed under Cognitive Dysfunction; 1,114 are open to participants now.

This study's enrollment of 135 is above the median of 64 across 2,855 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Universidad Católica San Antonio de Murcia is the lead sponsor of 138 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of Alzheimer's Disease
  • Older than 40 years of age
  • Male and female
  • Intellectual disability
  • Cognitive impairment
  • Able to do daily activities on his own
  • No presence of any other neurological and psychological disease
  • No presence of brain tumors

Exclusion criteria

Exclusion Criteria:

  • No presence of Alzheimer's Disease
  • Under 40 years old
  • Presence of brain tumors
  • Neurological patients
  • Presence of psychiatric disease
  • Depression symptoms
  • Presence of neuromuscular disease
  • Ictus
  • Aggressive patients
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
135 participants (actual)

Study arms

  • Experimental
    GPR Intervention Research group

    A total of 135 subjects with AD in the mild or moderate phase participated in the study from which 90 pertain to research group.The intervention implemented to the patients with AD was the Global Postural therapy which lasted about 30-40 min in repeated sessions of 2 meetings per week by making 48 sessions in total during a six month period.

    Other: GPR Intervention Research group

  • No intervention
    Control Group

    45 subjects of the study belongs to the control group which has not received the same treatment .

Interventions

  • OtherGPR Intervention Research group

    The research intervention consisted in the reappointment of three GPR therapeutic postures.

06

What researchers measure

Primary outcomes

  1. Cognitive Abilities Measurement

    The therapeutist provides the Mini Mental State Examination (MMSE) scale records. The evaluation consits in a 0-30 points-scale. Lower scores imply the severity of dementia.

    Time frame: Change from baseline cognitive evaluation at 6'th month

Secondary outcomes

  1. Quality of Life in Alzheimer's disease (QoL-AD) Questionnaire

    The therapeutist measures in the begining and in the end of the study the quality of life in patients with Alzheimer's disease (QoL-AD). This questionnaire consists in 13 elements referring to the perception that patients have concerning various aspects of their life: mood, health, cognition, environment and functional capacity. The range of scores is 13-52, were higher scores indicate a better life quality.

    Time frame: Change from baseline cognitive evaluation at 6'th month

  2. Geriatric Depression Scale (GDS) Questionnaire

    The version of 15 articles was used, which given its length can be validly and reliably resolved by patients themselves in the quality of a self-report questionnaire aiming to investigate the possible presence of depressive symptoms.

    Time frame: Change from baseline cognitive evaluation at 6'th month

  3. Barthel Index (BI)

    This scale is used by therapist to measure the performance in the basic activities of daily life of AD patients. The maximum score used is 100 points and refers to the patient's independence in all basic daily living activities.

    Time frame: Change from baseline cognitive evaluation at 6'th month

  4. Neuropsychiatric Inventory (NPI)

    This test includes 12 symptoms scored according to the phenomenon severity and frequency. It is a helpful instrument for the therapist because of specifically designed for the assessment of psycho-behavioral disorders in individuals with cognitive impairment.

    Time frame: Change from baseline cognitive evaluation at 6'th month

  5. Tinetti Scale (TS)

    The therapist used the equilibrium sub-scale, which consists in 7 elements and has a score between 0 and 13. Highest scores indicate a better balance.

    Time frame: Change from baseline cognitive evaluation at 6'th month

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Todri J, Lena O, Todri A, Fuentes JM. Does the Global Postural Re-Education Affect the Psychological and Postural Aspects of Alzheimer Disease Patients? A Six Months Quasi-Experimental Study. Curr Alzheimer Res. 2021;18(13):1057-1065. doi: 10.2174/1567205019666211223094811. PubMed 34951386 ↗

Individual participant data

Plan to share: No — All participants signed the informed consent and their family members were also informed concerning the purpose of the study. Correspondingly the data were provided by the physiotherapists who performed the above mentioned technique. Thereafter the study was validated and approved by the Ethics Committee of Catholic University of Murcia.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 19, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03732053
Responsible party
Jasemin Todri (PhD Candidate in Health Science, Universidad Católica San Antonio de Murcia) — Principal investigator
First posted
Nov 6, 2018
Start date
Dec 5, 2016
Primary completion
Mar 10, 2017
Completion
Jul 3, 2017
Last update
Nov 19, 2019

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion